EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop?

Expert Rev Clin Immunol. 2013 Feb;9(2):95-7. doi: 10.1586/eci.12.101.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Animals
  • Antibodies, Monoclonal / administration & dosage
  • CD3 Complex / immunology*
  • Clinical Trials, Phase III as Topic
  • Diabetes Mellitus, Type 1 / immunology
  • Diabetes Mellitus, Type 1 / therapy*
  • Drug Dosage Calculations
  • Epstein-Barr Virus Infections / immunology*
  • Herpesvirus 4, Human / immunology*
  • Humans
  • Immunosuppression Therapy
  • Mice
  • Mice, Inbred NOD
  • Treatment Failure
  • Tumor Necrosis Factor-alpha / metabolism*
  • Virus Activation

Substances

  • Antibodies, Monoclonal
  • CD3 Complex
  • Tumor Necrosis Factor-alpha